about
A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma.MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.The melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequences.alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen.A lineage-specific methylation pattern controls the transcription of the polycistronic mRNA coding MELOE melanoma antigens.A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming.p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell.A simple competitive assay to determine peptide affinity for HLA class II molecules: a useful tool for epitope prediction.Allogeneic T lymphocytes as a source of peptide-dependent T cells specific for myeloma cells.An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context.Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines.BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma.Predominant occurrence of somatic mutations of theNF2 gene in meningiomas and schwannomasIdentification of a gp100 epitope recognized by HLA-A3 restricted melanoma infiltrating lymphocytesp53 regulates CD46 expression and measles virus infection in myeloma cellsCharacterization of several DNA polymorphic markers in the LIF gene regionWhole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathwaysCharacterization of a VNTR sequence on human Chromosome 22 revealing polymorphic cross-hybridizing sequences in mammals
P50
Q30865419-3CC1FBAB-2218-4068-B70D-F4350D86560BQ33378044-64E7D341-A7E8-4090-8D8F-D5A38897F571Q35005458-C3154B8E-E997-4C36-AF54-D46499A3AD4AQ36402945-582F61AC-6F88-457A-9CE0-BDC605F59B71Q38875691-21C43306-53E7-40B5-AC5A-42597BB5A4DCQ39031562-7684A032-FF6A-40F0-9381-30FB74A32506Q39174104-9C054E6C-D716-4729-8A88-C68DFB12718EQ39512576-9F590163-5A00-4377-A9C4-24A0F286A14CQ40396193-25CEB3B8-0FC9-47EF-B955-4DF9288C269EQ42632718-3414EAAC-5D1E-40AE-BC85-F2CC65A591DFQ47218594-3516D7FA-8324-47F9-A1D3-C125C939F035Q50958153-E564C2C0-B13B-4CA1-B5A4-53903DCE5BC7Q53775870-AC1977E2-5C61-4526-AD55-3442287D1C23Q57304749-7A1707F1-7512-497A-8D7E-EC8775F177CEQ57729556-A32B98C9-4795-49F3-B274-998893B06171Q59789486-1BB4D94C-AC85-49E3-8DB3-6132A7076C5BQ60035769-3834144D-ABAD-4328-87C7-DAE3C2ECC8A4Q60045001-A494A198-EC2E-40CB-8181-DEE4C9D4E6F6Q72249400-9794F789-986F-4431-A309-AB6E40C7F5BA
P50
description
researcher
@en
wetenschapper
@nl
name
Agnes Moreau-Aubry
@en
Moreau-Aubry A
@nl
type
label
Agnes Moreau-Aubry
@en
Moreau-Aubry A
@nl
altLabel
Moreau-Aubry A
@en
prefLabel
Agnes Moreau-Aubry
@en
Moreau-Aubry A
@nl
P106
P31
P496
0000-0001-5540-3374